Sinovac says COVID-19 vaccine 100% effective in preventing hospitalization, death
China’s Sinovac Biotech on said late-stage trial data of its COVID-19 vaccine from Brazil and Turkey showed it prevented hospitalization and death in COVID-19 patients, but had a much lower efficacy rate in blocking infections, SİA reports citing Reuters.
The 12,396-person trial found the CoronaVac vaccine was 100% effective in preventing COVID-19 sufferers from being hospitalized or dying and 83.7% effective in avoiding cases that required any medical treatment, but only 50.65% effective at keeping people from getting infected, according to a statement.
The trials evaluated the efficacy of the two-shot vaccine candidate 14 days after inoculation of participants, including healthcare workers who treat COVID-19 patients.
Bütün xəbərlər Facebook səhifəmizdə
- USD 1,7000 0,00%
- EUR 2,0237 0,00%
- GBP 2,3347 0,00%
- RUB 0,0221 0,00%